325 related articles for article (PubMed ID: 31183445)
21. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
22. Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma.
Song E; Ahn J; Song DE; Kim WW; Jeon MJ; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Hong SJ; Lee YM; Kim WG
Clin Endocrinol (Oxf); 2020 Apr; 92(4):358-365. PubMed ID: 31630423
[TBL] [Abstract][Full Text] [Related]
23. Central lymph node dissection and permanent hypoparathyroidism after total thyroidectomy for papillary thyroid cancer: population-based study.
Salem FA; Bergenfelz A; Nordenström E; Almquist M
Br J Surg; 2021 Jun; 108(6):684-690. PubMed ID: 34157088
[TBL] [Abstract][Full Text] [Related]
24. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
Macedo FI; Mittal VK
Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
[TBL] [Abstract][Full Text] [Related]
25. Additional Surgery for Occult Risk Factors After Lobectomy in Solitary Thyroid Nodules is Predicted by Cytopathology Classification and Tumor Size.
Flagg A; Rooper L; Sheth S; Shaear M; Santhanam P; Prescott J; Olson MT; Bishop JA; Mammen JS
Endocr Pract; 2020 Jul; 26(7):754-760. PubMed ID: 33471644
[TBL] [Abstract][Full Text] [Related]
26. Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?
Ma T; Wang H; Liu J; Zou J; Liu S
Front Endocrinol (Lausanne); 2021; 12():723631. PubMed ID: 34434171
[TBL] [Abstract][Full Text] [Related]
27. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
Lang BH; Wong CKH
Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
[TBL] [Abstract][Full Text] [Related]
28. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients.
Cho JW; Lee YM; Lee YH; Hong SJ; Yoon JH
Clin Endocrinol (Oxf); 2018 Jul; 89(1):100-109. PubMed ID: 29672893
[TBL] [Abstract][Full Text] [Related]
29. Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: A National Survey of Low- and High-Volume Surgeons.
McDow AD; Saucke MC; Marka NA; Long KL; Pitt SC
Ann Surg Oncol; 2021 Jul; 28(7):3568-3575. PubMed ID: 33939048
[TBL] [Abstract][Full Text] [Related]
30. Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.
Bakkar S; Al-Omar K; Donatini G; Aljarrah Q; Papavramidis TS; Materazzi G; Miccoli P
Endocrine; 2021 Dec; 74(3):611-615. PubMed ID: 34110601
[TBL] [Abstract][Full Text] [Related]
31. Thyroid lobectomy for low-risk thyroid cancers.
Puttergill B; Khan S; Christakis I; Dumbill R; Mclaren A; Sadler G; Mihai R
Ann R Coll Surg Engl; 2022 Feb; 104(2):113-116. PubMed ID: 35100851
[TBL] [Abstract][Full Text] [Related]
32. Complication rates of central compartment dissection in papillary thyroid cancer.
Kwan WY; Chow TL; Choi CY; Lam SH
ANZ J Surg; 2015 Apr; 85(4):274-8. PubMed ID: 23890372
[TBL] [Abstract][Full Text] [Related]
33. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
34. Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population.
Sharma RK; Huang B; Lee JA; Kuo JH
J Surg Res; 2021 Jul; 263():207-214. PubMed ID: 33690052
[TBL] [Abstract][Full Text] [Related]
35. Patient Preferences Around Extent of Surgery in Low-Risk Thyroid Cancer: A Discrete Choice Experiment.
Ahmadi S; Gonzalez JM; Talbott M; Reed SD; Yang JC; Scheri RP; Stang M; Roman S; Sosa JA
Thyroid; 2020 Jul; 30(7):1044-1052. PubMed ID: 32143553
[No Abstract] [Full Text] [Related]
36. The time point of completion thyroidectomy has no prognostic impact in patients with differentiated thyroid cancer.
Lenschow C; Mäder U; Germer CT; Reiners C; Schlegel N; Verburg FA
Clin Endocrinol (Oxf); 2019 Mar; 90(3):479-486. PubMed ID: 30548672
[TBL] [Abstract][Full Text] [Related]
37. Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018).
Pasqual E; Sosa JA; Chen Y; Schonfeld SJ; Berrington de González A; Kitahara CM
Thyroid; 2022 Apr; 32(4):397-410. PubMed ID: 35078347
[No Abstract] [Full Text] [Related]
38. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
39. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
Tsui KP; Kwan WY; Chow TL
Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
[TBL] [Abstract][Full Text] [Related]
40. Less extensive surgery for low-risk papillary thyroid cancers post 2015 American Thyroid Association guidelines in an Australian tertiary centre.
Adhami M; Bhatt CR; Grodski S; Serpell J; Lee JC
Eur J Surg Oncol; 2021 Nov; 47(11):2781-2787. PubMed ID: 34364721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
